eGenesis, a Cambridge-based startup, is addressing the shortage of available organs for transplant by developing effective human transplantable organs using CRISPR technology to modify pig organs.
Read More

Are you curious about the relationship between genetics and memory, attention, and reaction speed? Online brain game company, Lumosity, and George Church’s Harvard research team have joined together to explore genetics and memory with potential to lead to groundbreaking technologies in understanding diseases like Alzheimer’s.
Read More

Neurovance, a Cambridge-based pharmaceutical company has been acquired by Otsuka Pharmaceuticals. Neurovance is a clinical stage pharmaceutical company focused on attention-deficit hyperactivity disorder (ADHD) in children and adults.
Read More

Researchers find correlations between diabetes and cancer and how the type II diabetes drug, Metformin treats them both.
Read More

Cambridge-based Seres Therapeutics plans to test potentially breakthrough microbiome drug, SER-109. If successful, SER-109 could go on to treat bacterial infection Clostridium difficile, which can occur as a result of using antibiotics.
Read More

 



Jobs

Associate Scientist – Fulcrum Therapeutics, Cambridge, MA
Job Site

Senior Scientist – Pharmacology – Ironwood Pharmaceuticals, Cambridge, MA
Job Site

Bioinformatics Analyst – Brigham & Women’s Hospital, Boston, MA
Job Site

Go Back